Baldness Drug Stocks like Veradermics (MANE) and Absci (ABSI) Are Chasing the Same Wall Street Magic as Ozempic
Veradermics (MANE) shares have risen nearly 500% since its February 2026 IPO, while Absci (ABSI) stock is up more than 100% in 2026, as investors bet on a new wave of male and female hair-loss drugs after the GLP-1 weight-loss boom.
Sep 12, 2026 ·
Yahoo Finance



















